Register
BioNTech logo on a glass partition overlooking a pharmaceutical cleanroom corridor with blue-framed doors

INSIGHTS

8 Jun 2026

After Covid, BioNTech Wants to Beat Cancer

BioNTech commences a USD 1.0 billion share repurchase program to optimize capital efficiency during its multi-product clinical pivot into ...

Close-up clinical image of a pigmented melanoma lesion with irregular dark brown borders on pale skin

INNOVATION

3 Jun 2026

The mRNA Cancer Vaccine Changing Melanoma's Odds

Five-year trial data show a personalised mRNA vaccine slashed melanoma recurrence by 49% alongside immunotherapy

Close-up of Moderna red logo letters on a grey building facade with a row of blue rectangular tiles beneath

MARKET TRENDS

28 May 2026

Two in One: Europe Clears First Dual Respiratory Shot

Europe approves Moderna’s mCOMBRIAX, the first single-dose vaccine targeting both flu and COVID-19 for adults aged 50 and up

Speaker at a lectern facing a blue LED screen displaying NanoForge AI branding in Chinese and English

INNOVATION

20 May 2026

The Nanoparticle That Finally Found the Heart

METiS TechBio achieves ~100% cardiac cell delivery via AI-designed LNPs in a world-first preclinical result

Three researchers in lab coats holding molecular model structures in a well-equipped laboratory setting

INNOVATION

15 May 2026

The Nanoparticle That Skips the Liver

Penn engineers redesign nanoparticles to target lymph nodes, cutting liver delivery tenfold with no loss of immune potency

Neoclassical building entrance with a Latin inscription and stone eagle above the cornice

TECHNOLOGY

13 May 2026

Disorder Wins: a Breakthrough in mRNA Delivery

Copenhagen scientists find disordered LNPs release mRNA more effectively, reshaping drug delivery design

topics on the agenda

ESTABLISHING AN “RNA COOPERATIVE” TO CO-DEVELOP AN mRNA VACCINE

Day 1: WEDNESDAY, 22 JULY, 2026

09:00 - 09:25

NOVEL APPROACH TO IDENTIFY BIOMARKERS FOR mRNA-BASED THERAPEUTICS AND VACCINES

Day 1: WEDNESDAY, 22 JULY, 2026

09:30 - 09:55

ENABLING RAPID mRNA VACCINE DEVELOPMENT WITH CELL-FREE DNA TEMPLATES FOR PANDEMIC PREPAREDNESS

Day 1: WEDNESDAY, 22 JULY, 2026

10:00 - 10:25

View more topics

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.